Insulet Corporation is an innovative medical device company that aims to improve the lives of people with diabetes and other conditions through its Omnipod delivery system. The company was founded in 2000 and is dedicated to simplifying the lives of people with diabetes through its tubeless, wearable, Pod-based insulin management systems.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

COM:INSULET

Insulet Corporation

Last Close

266.58

21/11 14:58

Market Cap

13.84B

Beta: -

Volume Today

44.02K

Avg: -

market

industry

website

crunchbase

ipo date

investor of

competitor of

Metrics